Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) is expected to release its results before the market opens on Thursday, August 20th. Analysts expect Novozymes A/S to announce earnings of $0.60 per share and revenue of $1.2675 billion for the quarter.
Novozymes A/S Trading Down 1.8%
OTCMKTS:NVZMY opened at $64.45 on Tuesday. Novozymes A/S has a 52 week low of $49.90 and a 52 week high of $66.66. The firm has a 50 day moving average of $63.20 and a 200 day moving average of $60.45. The company has a quick ratio of 1.03, a current ratio of 1.67 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $26.72 billion, a price-to-earnings ratio of 43.55, a PEG ratio of 3.07 and a beta of 0.92.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on NVZMY shares. Zacks Research raised Novozymes A/S from a “strong sell” rating to a “hold” rating in a research report on Monday, June 8th. Kepler Capital Markets raised Novozymes A/S from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, May 13th. Two research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, Novozymes A/S presently has a consensus rating of “Buy”.
About Novozymes A/S
Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.
The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).
Featured Stories
- Five stocks we like better than Novozymes A/S
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
